Press Releases

Covisint, A Compuware Company, Announces "Last Real Chance" For Physicians To Easily Collect Federal PQRI Payments

Stock quotes in this article:CPWR 

DETROIT, March 4, 2011 (GLOBE NEWSWIRE) -- Covisint, a Compuware (Nasdaq:CPWR) company, today announced that physicians and care provider organizations are nearing the absolute deadline for processing submittals to the Centers for Medicare & Medicaid Services (CMS) for the 2010 Physician Quality Reporting Initiative (PQRI). Leveraging Covisint DocSite™ PQRI, physicians and practice managers can now submit 2010 PQRI data through March 15, 2011.

Compuware Logo
Covisint Logo

Covisint is one of a few remaining services still available for submittals, and Covisint DocSite PQRI continues to make reporting on PQRI and receiving incentives from CMS easy for doctors and hospitals. CMS offers revenue incentives for delivering excellent care through participation in this voluntary quality reporting program. Healthcare organizations choose Covisint because of its proven, cost-effective way to manage and execute on payment reporting for physicians regarding data on quality measures.

Covisint outpaced all competitors by completing more than 4,500 submissions for 2010 incentives, a 300 percent year-over-year increase in the submission rate. Because of this, providers have obtained anywhere from hundreds of dollars to hundreds of thousands of dollars.

"Covisint has quantifiably dominated the industry in terms of taking the pain out of submitting for PQRI," said Brett Furst, Vice President of Healthcare for Covisint. "Our Covisint DocSite PQRI solution helps deserving organizations obtain government funds for encouraging health IT adoption. The window is closing, but there is still time left for Covisint to help healthcare organizations obtain the funds that are rightfully theirs."

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,454.83 1,317.82 2,837.53 17.45
Oil *
107.26
DOWN
74.92
DOWN
2.86
DOWN
1.85
DOWN
0.14
10 Yr
1.74%
SPDR Gold
152.68
-0.60%
-0.22%
-0.07%
-0.80%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet